source
- Patient advocates and experts raise alarm over safety of Neurocrine Biosciences rare disease drugTwo months after an open letter highlighted possible safety issues, patient advocacy groups and several experts are publicly voicing growing alarm about a rare disease therapy marketed by Neurocrin…
- Trump administration proposes $70,000 fee to curb foreign student work authorizationsThe Department of Homeland Security announced a proposed $70,000 fee for a work authorization program that many foreign students and scholars use to gain professional experience in the United State…